The study's results suggest that both GLP-1 and GIP suppress bone resorption
The supplement and peptide industry is largely unregulated
Retrieved from Centers for Disease Control and Prevention (CDC)
The lawsuit is a private Lanham Act and state unfair-competition action, not an FDA enforcement proceeding, and its outcome (an injunction, corrective advertising, damages) would affect Lilly's marketing materials, not the FDA-approved product labels for Zepbound or Mounjaro
Some semaglutide formulations also have both B6 and B12 to help relieve side effects, such as nausea, or prevent lethargy and fatigue in patients taking GLP-1 drugs for weight loss or type 2 diabetes
Both compounds share similar gastrointestinal side effects